Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qihong Tongnao Mixture
- Development stage
- Preclinical
- Lead developer
- The Second Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Qihong Tongnao Mixture (芪红通脑合剂) is a traditional Chinese medicine hospital preparation developed by the Second Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine. It is formulated to treat acute ischemic stroke and cerebral arterial thrombosis, specifically targeting patients presenting with the traditional Chinese medicine syndrome of qi deficiency and blood stasis. The mixture is administered orally as an adjunct to conventional Western medical treatments to improve clinical efficacy and safety, and it has also been studied in combination with repetitive transcranial magnetic stimulation (rTMS) for post-stroke cognitive impairment.
- Other names
- 芪红通脑合剂
Beyond the preview
Go deeper on Qihong Tongnao Mixture.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qihong Tongnao Mixture.